“Leucine-Rich Alpha-2-Glycoprotein as Biomarker for Predicting Endoscopic Remission in Ulcerative Colitis Patients”

https://pubmed.ncbi.nlm.nih.gov/38115911

The abstract reports a study finding that Leucine-rich alpha-2-glycoprotein (LRG) can be a useful biomarker for predicting endoscopic remission in patients with ulcerative colitis, independent of their symptoms.